SCOTS-KNIGHT DENISE (Chief Executive Officer) sold 9.9% of their position (88.66K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $381.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/16/2024ACC: 0000950170-24-106976
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-88.66K
Net shares
Net seller
$381.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
88.66K disposed
Non-Derivative Transactions2
American Depositary Shares representing Ordinary Shares
Direct
Shares
−28.61K
Price / share
$4.47
Trade value
$127.97K
% of position
3.2%
9/12/2024
897.58K→868.97K
American Depositary Shares representing Ordinary Shares
Direct
Shares
−60.05K
Price / share
$4.22
Trade value
$253.45K
% of position
6.9%
9/13/2024
868.97K→808.92K
Total
Net shares
−88.66K
Net value
-$381.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 9/12/2024 | S · Sale | −28.61K | $4.47 | $127.97K | 3.2% | 897.58K | 868.97K |
| American Depositary Shares representing Ordinary Shares Direct | 9/13/2024 | S · Sale | −60.05K | $4.22 | $253.45K | 6.9% | 868.97K | 808.92K |
| Total | −88.66K | -$381.42K | ||||||
Derivative Transactions0
No derivative transactions reported